Table 6 Influencing factors of liver injury in the Omicron BA.5.2 patients

N

173

26

Male

89 (51.4%)

21 (80.8%)

7.862

0.005

0.000

0.999

Age (years)

51.25 ± 13.54

53.04 ± 13.43

0.627

0.531

Vaccination History

171 (98.8%)

26 (100.0%)

0.304

0.589

Classification

 Mild

102 (59.0%)

12 (46.2%)

1.515

0.281

 Common

71 (41.0%)

14 (53.8%)

Comorbidities

43 (24.9%)

6 (23.1%)

0.039

0.844

BMI

24.47 ± 3.93

26.70 ± 4.14

2.364

0.020

0.357

0.550

SpO₂ (%)

97.44 ± 1.56

97.88 ± 1.21

1.384

0.168

T (℃)

37.34 ± 0.95

37.47 ± 1.19

0.613

0.540

ALB(g·L^-1)

43.83 ± 1.87

43.72 ± 2.73

0.291

0.772

WBC(×10⁹ L^-1)

1.58 ± 1.50

4.79 ± 1.52

0.657

0.512

CRP(mg·L^-1)

9.02 ± 11.07

23.01 ± 31.12

4.377

0.000

6.067

0.010

IL-6(pg.mL^-1)

10.24 ± 41.36

21.22 ± 40.13

1.047

0.299

D-dimer(mg·L^-1)

0.34 ± 0.51

0.40 ± 0.35

0.299

0.766

PT (second)

10.46 ± 0.78

10.48 ± 1.10

0.074

0.941

INR

0.89 ± 0.07

0.90 ± 0.11

0.169

0.866

Therapeutic drugs

   Antibiotic

6 (3.5%)

1 (3.8%)

0.009

0.093

 Chinese patent medicine

133 (76.9%)

16 (61.5%)

8.827

0.093